News

SORT BY YEAR
10 May, 2019

Ally Bridge Portfolio News – Pulmonx Closes $65 Million Financing and Adds Chief Financial Officer

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies, announced today the closing of an oversubscribed $65 million equity financing and the hiring of Derrick Sung, Ph.D. as its Chief Financial Officer. The financing was led by Ally Bridge Group, a leading global life science-dedicated investment group, and included other […]

Read More
10 May, 2019

Ally Bridge Group Leads Pulmonx’s $65 Million Financing, Further Strengthening Its Global Medtech Franchise

HONG KONG, May 9, 2019 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading global life science investment group, announced today that it led an over-subscribed $65 million financing of Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies with its key product approved and marketed in the US, Europe, Australia, and Asia, including China. Pulmonx is focused on developing life-changing technologies […]

Read More
4 April, 2019

Ally Bridge, LifeTech Scientific and Quantum Surgical Announce Three-Way China Joint Venture to Develop Innovative Surgical Robot for the Treatment of Liver Cancer

HONG KONG, SHENZHEN, China, and Montpellier, France, April 4, 2019 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading cross-border life science investment group, announced today that it has entered into an agreement with LifeTech Scientific Corporation (SEHK: 1302) (“LifeTech”), a leading medical device company in China, and Quantum Surgical, an innovative surgical robotics company in […]

Read More
8 March, 2019

Ally Bridge Portfolio News – ShockWave Medical shares soared by more than 79% in its Wall Street debut

ShockWave Medical Inc. shares soared by more than 79 percent in its Wall Street debut on Thursday after it raised nearly $97 million in an upsized IPO. The Santa Clara life sciences company sold 5.7 million shares of common stock for $17 a share. That was about 700,000 more shares than were expected to be […]

Read More
8 March, 2019

Ally Bridge Portfolio News – ShockWave Medical prices upsized IPO above the range at $17

SANTA CLARA, Calif., March 06, 2019 (GLOBE NEWSWIRE) — ShockWave Medical, Inc. (“ShockWave”) today announced the pricing of its initial public offering of 5,700,000 shares of its common stock at a price to the public of $17.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market on March 7, […]

Read More
13 December, 2018

Ally Bridge Portfolio News – WuXi AppTec Completes Secondary Listing in HKEx After Fast-Track A-Share IPO

HONG KONG and SHANGHAI, December 12, 2018– WuXi AppTec Co., Ltd. (Stock code: 603259.SH/2359.HK) today announced the successful secondary listing on the Main Board of the Hong Kong Stock Exchange,  just seven months after it went public in Shanghai via a fast-tracked listing. Based on the offer price of HK$68 per share, the net proceeds to […]

Read More
13 December, 2018

Ally Bridge Portfolio News – Wuxi Apptec Successfully Prices Hong Kong Offering in Stormy market

BioCentury – Dec 8, 2018 Despite global trade headwinds and a choppy market for biopharma stocks in China, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) successfully price its Hong Kong listing within its proposed range Friday, raising HK$7.9 billion ($1 billion) based on its proposed number of shares. The listing is the third for a unit […]

Read More
6 December, 2018

Ally Bridge Portfolio News – TESARO reaches agreement to be acquired by GSK

LONDON and WALTHAM, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) today announced that the Companies have entered into a definitive agreement pursuant to which GSK will acquire TESARO, an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash consideration of approximately $5.1 billion (£4.0 billion). The proposed transaction significantly strengthens GSK’s pharmaceutical business, […]

Read More
15 November, 2018

Ally Bridge Portfolio News – Vapotherm Shares Soar 14.29% in Trading Debut

Vapotherm Inc, which provides noninvasive breathing aids to treat respiratory distress, raised $56 million by offering 4 million shares at $14. The stock started trading on the New York Stock Exchange Wednesday, under the ticker symbol “VAPO”. BofA Merrill Lynch and William Blair were bookrunners on the deal with Canaccord and BTIG acting as co-managers. Proceeds […]

Read More
1 November, 2018

Ally Bridge Portfolio News – Axonics IPO Opened Strong at $16.05/Share (+7%), against a fragile market

October 30, 2018 Business Wire RVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc. (“Axonics”), a medical technology company focused on the design, development and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions for the treatment of overactive bladder (“OAB”), fecal incontinence (“FI”), and urinary retention (“UR”), today announced the pricing of its initial public offering […]

Read More